Michael Peri

Relay is built for both wholesale brokers and retail agents. It equips them with a friendly interface to easily add specialty lines to their client proposals. Relay lets agencies and brokerages quickly add Cyber Insurance to any quote, and also supports Management Liability and Small Commercial/BOP. Forward-looking agencies and brokerages in North America use Relay to place more business, faster and better.

Personalized, clinician-backed care for the full spectrum of digestive issues, delivered through our virtual health platform as an employer-sponsored benefit.

Axio is the leader in SaaS-based cyber management software, which empowers security leaders to build and optimize security programs and quantify risk in financial terms. Axio360 is the only cyber risk management platform to align security leaders, business leaders, and Boards of Directors around a single source of truth about their most critical corporate risks. Since 2016, Axio has been a trusted partner to many of the world’s leading critical infrastructure, energy, manufacturing, and financial services companies, helping drive better visibility and decision-making about cybersecurity priorities and investments. For more information visit axio.com

Wellth is the daily member relationship platform, proven across millions of members. Healthcare assumes people act in their own best interest. But everyday stress gets in the way, and for members managing chronic conditions, good habits are hard to build and harder to keep. Wellth changes that. We partner with Medicare Advantage, D-SNP, Medicaid, and commercial plans to build a daily relationship with every member, grounded in behavioral science and validated in a Penn Medicine randomized controlled trial. We handle the full journey, from onboarding and activation to bringing members back day after day. Instead of one more vendor pinging members out of context, Wellth becomes the one positive, consistent touchpoint that helps people build the daily behaviors that drive clinical, cost, and quality outcomes: taking blood pressure readings, testing blood sugar, using connected devices, eating healthy meals, managing their care plans, and more. Proven across diverse populations: • 90% average care plan adherence • 45% reduction in post-ACS hospital readmissions (Penn Medicine RCT) • 43% average reduction in high-cost utilization • 51% lower inpatient admissions • 2-4x ROI on cost-of-care reduction • 4+ Star Ratings across Part C and D measures 70 million daily check-ins and counting. Learn more at www.wellthapp.com.

The Healthtech Fund is an Alumni Ventures venture capital fund that focuses on ventures innovating in healthtech and life sciences. We are part of Alumni Ventures, America’s largest venture firm for individual investors. Founded in 2014, we are the venture investing partner to over 11,000 individuals and institutions.   Follow the Healthtech Fund for content at the intersection of entrepreneurship, venture capital, and specific industry sectors. We are a private, for-profit organization. Offers of securities are made only to eligible investors through formal offering documents, which describe the risks, terms, and other important information that must be considered before investing. Example portfolio company investments shown for illustrative purposes only, do not necessarily reflect investment outcomes that were or would be obtained by any AV fund or investor, and are not available to future investors, except potentially in the case of follow-on investments. Venture capital investing involves substantial risk, including risk of loss of all capital invested. Past performance does not guarantee future results.

Founded in 2014, we’re America’s largest venture firm for individual investors and VC investing partner to over 11,000 individuals and institutions. Offerings include institutional-grade funds with large diversified portfolios and deal-by-deal investing through our Syndicates. Investment minimum is $10,000. • Top-20 VC Firm (Time Magazine ’25) • Top-Decile Investment Performance (Carta Benchmarks ‘25) • Top 20 VC Firm (CB Insights 24) • Top 50 Unicorn VC (Stanford GSB Research ‘25) • Top 3 Most Active US VC Firm (PitchBook ‘18 - ‘24) • Most Founder Friendly Investor List (Inc. Magazine ‘24) • Worlds Most Innovative Companies (Fast Company 22) • #1 Most Active Venture Firm in the US (PitchBook 22 & 23) • Top 20 Venture Firm (CB Insights 24) • Worlds Most Innovative Companies (Fast Company 22) • Portfolio of 1,600+ current and historical companies • 40+ full-time VC investors • Founders get access to our community of 850,000+ members and 6,000+ Experts. Offers of securities made only to eligible investors by formal offering documents describing risks, terms, and other important information that must be considered before investing. Example portfolio companies shown for illustrative purposes only, do not necessarily reflect investment outcomes that were or would be obtained by any AV fund or investor, and are not available to future investors, except potentially in follow-on investments. Venture capital investing involves substantial risk, including risk of loss of all capital invested. Past performance does not guarantee future results. The content on this account is intended solely for persons located in the U.S. and is not directed at, and must not be acted upon, by any person in the United Kingdom. UK residents seeking information about AV should refer only to communications issued by Alumni Ventures UK LLP, which provides information solely on a non-promotional basis and only distributes Financial Promotions to eligible recipients in accordance with UK law.

Lakeshore Ventures is an Alumni Ventures venture capital fund for alumni of UChicago that invests in companies with a UChicago connection. Meet the team: David Beazley, Managing Partner Mike Peri, Partner Lucas Pasch, Principal Justin Strausbaugh, Partner Emeritus We are part of Alumni Ventures, America’s largest venture fund for individuals and the #1 most active venture firm in the US and #3 globally (PitchBook 2022). Follow Lakeshore Ventures for content at the intersection of our shared alma mater, venture capital, and entrepreneurship. We are private, for-profit, and not affiliated with or sanctioned by the university.

Purple Arch Ventures is an Alumni Ventures venture capital fund for alumni of Northwestern that invests in companies with a Northwestern connection. Meet the team: David Beazley, Managing Partner Mike Peri, Partner Lucas Pasch, Principal We are part of Alumni Ventures, America’s largest venture fund for individuals and the #1 most active venture firm in the US and #3 globally (PitchBook 2022). Follow Purple Arch Ventures for content at the intersection of our shared alma mater, venture capital, and entrepreneurship. We are private, for-profit, and not affiliated with or sanctioned by the university.

CVS Health is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and over 300,000 dedicated colleagues – including more than 40,000 physicians, pharmacists, nurses and nurse practitioners. Wherever and whenever people need us, we help them with their health – whether that’s managing chronic diseases, staying compliant with their medications or accessing affordable health and wellness services in the most convenient ways. We help people navigate the health care system – and their personal health care – by improving access, lowering costs and being a trusted partner for every meaningful moment of health. And we do it all with heart, each and every day. Follow @CVSHealth on social media.